2 patient evaluations for Ocrelizumab
Sort by:
Most recent
Apr 20, 2018 (Started )
-
EffectivenessMajor (for multiple sclerosis)
-
Side effectsNone
-
AdherenceAlways
-
BurdenSomewhat hard to take
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
- 0 helpful marks
Sep 29, 2017 (Started Sep 25, 2017)
-
EffectivenessSlight (for multiple sclerosis)
-
Side effectsMild (nausea)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
30 mg
Every 6 months
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
- 1 helpful mark
Last updated:
Showing 2 of 2 patient evaluations for Ocrelizumab